|

Nektar Therapeutics’ Business Transformation

Nektar Therapeutics is transforming its business model, shifting from PEGylation drug delivery to innovative immunotherapy and autoimmune treatments. This strategic evolution marks a new chapter in its biotech journey toward sustainable growth and medical

By Andrew Bennett | November 01, 2025 | 0 Comments